Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Iα

Science

Volumn 286, Issue 5444, 1999, Pages 1583-1587

  Surks, Howard K ^a   Mochizuki, Naoki ^a,b   Kasai, Yasuyo ^a   Georgescu, Serban P ^a   Tang, K Mary ^a   Ito, Masaaki ^c   Lincoln, Thomas M ^d   Mendelsohn, Michael E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; LEUCINE; MYOSIN; MYOSIN LIGHT CHAIN KINASE; NITRIC OXIDE; PHOSPHATASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; ENZYME REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE TONE;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HISTONES; HUMANS; ISOENZYMES; LEUCINE ZIPPERS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PRECIPITIN TESTS; RATS; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0033584786     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.286.5444.1583     Document Type: Article

References (61)

1. K E. Kamm and J T. Stull, Annu Rev Pharmacol. Toxicol. 25, 593 (1985); D J Hartshorne, in Physiology of the Gastrointestinal Tract, D. R. Johnson, Ed. (Raven, New York, ed. 2, 1987), vol. 1, pp. 423-482; R. S. Filo, D. F. Bohr, J. C Ruegg, Science 147, 1581 (1965); A. P. Somlyo and B. Himpens, FASEB J. 3, 2266 (1989).
2. K E. Kamm and J T. Stull, Annu Rev Pharmacol. Toxicol. 25, 593 (1985); D J Hartshorne, in Physiology of the Gastrointestinal Tract, D. R. Johnson, Ed. (Raven, New York, ed. 2, 1987), vol. 1, pp. 423-482; R. S. Filo, D. F. Bohr, J. C Ruegg, Science 147, 1581 (1965); A. P. Somlyo and B. Himpens, FASEB J. 3, 2266 (1989).
3. K E. Kamm and J T. Stull, Annu Rev Pharmacol. Toxicol. 25, 593 (1985); D J Hartshorne, in Physiology of the Gastrointestinal Tract, D. R. Johnson, Ed. (Raven, New York, ed. 2, 1987), vol. 1, pp. 423-482; R. S. Filo, D. F. Bohr, J. C Ruegg, Science 147, 1581 (1965); A. P. Somlyo and B. Himpens, FASEB J. 3, 2266 (1989).
4. K E. Kamm and J T. Stull, Annu Rev Pharmacol. Toxicol. 25, 593 (1985); D J Hartshorne, in Physiology of the Gastrointestinal Tract, D. R. Johnson, Ed. (Raven, New York, ed. 2, 1987), vol. 1, pp. 423-482; R. S. Filo, D. F. Bohr, J. C Ruegg, Science 147, 1581 (1965); A. P. Somlyo and B. Himpens, FASEB J. 3, 2266 (1989).
5. A. P. Somlyo and A. V. Somlyo, Nature 372, 231 (1994)
6. D. Alessi, L. K. MacDougall, M. M. Sola, M. Ikebe, P. Cohen, Eur. J. Biochem. 210, 1023 (1992); K. Hirano, B. C. Phan, D. J. Hartshorne, J. Biol. Chem. 272, 3683 (1997); D. F. Johnson et al., Eur. J. Biochem. 239, 317 (1996); H. Shimizu et al., J. Biol. Chem 269, 30407 (1994).
7. D. Alessi, L. K. MacDougall, M. M. Sola, M. Ikebe, P. Cohen, Eur. J. Biochem. 210, 1023 (1992); K. Hirano, B. C. Phan, D. J. Hartshorne, J. Biol. Chem. 272, 3683 (1997); D. F. Johnson et al., Eur. J. Biochem. 239, 317 (1996); H. Shimizu et al., J. Biol. Chem 269, 30407 (1994).
8. D. Alessi, L. K. MacDougall, M. M. Sola, M. Ikebe, P. Cohen, Eur. J. Biochem. 210, 1023 (1992); K. Hirano, B. C. Phan, D. J. Hartshorne, J. Biol. Chem. 272, 3683 (1997); D. F. Johnson et al., Eur. J. Biochem. 239, 317 (1996); H. Shimizu et al., J. Biol. Chem 269, 30407 (1994).
9. D. Alessi, L. K. MacDougall, M. M. Sola, M. Ikebe, P. Cohen, Eur. J. Biochem. 210, 1023 (1992); K. Hirano, B. C. Phan, D. J. Hartshorne, J. Biol. Chem. 272, 3683 (1997); D. F. Johnson et al., Eur. J. Biochem. 239, 317 (1996); H. Shimizu et al., J. Biol. Chem 269, 30407 (1994).
10. B. Bradley and K. G. Morgan, J. Physiol (London) 385, 437 (1987); T. Kitazawa, B. D. Gaylinn, G. H. Denney, A P. Somlyo, J. Biol. Chem. 266, 1708 (1991); M. Masuo, S. Reardon, M Ikebe, T. Kitazawa, J. Gen. Physiol. 104, 265 (1994), M. Cui Gong et al., J. Biol. Chem. 267, 21492 (1992), K. Kimura et al , Science 273, 245 (1996).
11. B. Bradley and K. G. Morgan, J. Physiol (London) 385, 437 (1987); T. Kitazawa, B. D. Gaylinn, G. H. Denney, A P. Somlyo, J. Biol. Chem. 266, 1708 (1991); M. Masuo, S. Reardon, M Ikebe, T. Kitazawa, J. Gen. Physiol. 104, 265 (1994), M. Cui Gong et al., J. Biol. Chem. 267, 21492 (1992), K. Kimura et al , Science 273, 245 (1996).
12. B. Bradley and K. G. Morgan, J. Physiol (London) 385, 437 (1987); T. Kitazawa, B. D. Gaylinn, G. H. Denney, A P. Somlyo, J. Biol. Chem. 266, 1708 (1991); M. Masuo, S. Reardon, M Ikebe, T. Kitazawa, J. Gen. Physiol. 104, 265 (1994), M. Cui Gong et al., J. Biol. Chem. 267, 21492 (1992), K. Kimura et al , Science 273, 245 (1996).
13. B. Bradley and K. G. Morgan, J. Physiol (London) 385, 437 (1987); T. Kitazawa, B. D. Gaylinn, G. H. Denney, A P. Somlyo, J. Biol. Chem. 266, 1708 (1991); M. Masuo, S. Reardon, M Ikebe, T. Kitazawa, J. Gen. Physiol. 104, 265 (1994), M. Cui Gong et al., J. Biol. Chem. 267, 21492 (1992), K. Kimura et al , Science 273, 245 (1996).
14. B. Bradley and K. G. Morgan, J. Physiol (London) 385, 437 (1987); T. Kitazawa, B. D. Gaylinn, G. H. Denney, A P. Somlyo, J. Biol. Chem. 266, 1708 (1991); M. Masuo, S. Reardon, M Ikebe, T. Kitazawa, J. Gen. Physiol. 104, 265 (1994), M. Cui Gong et al., J. Biol. Chem. 267, 21492 (1992), K. Kimura et al , Science 273, 245 (1996).
15. A. Pfeifer et al , EMBO J. 17, 3045 (1998); T. M. Lincoln, in Cyclic GMP: Biochemistry, Physiology and Pathophysiology (R. G. Landes Company, Austin, TX, 1994), pp. 97-115; S. M Lohmann, A. B. Vaandrager, A. Smolenski, U Walter, H. R. DeJonge, Trends Biochem. Sci. 22, 307 (1997).
16. A. Pfeifer et al , EMBO J. 17, 3045 (1998); T. M. Lincoln, in Cyclic GMP: Biochemistry, Physiology and Pathophysiology (R. G. Landes Company, Austin, TX, 1994), pp. 97-115; S. M Lohmann, A. B. Vaandrager, A. Smolenski, U Walter, H. R. DeJonge, Trends Biochem. Sci. 22, 307 (1997).
17. A. Pfeifer et al , EMBO J. 17, 3045 (1998); T. M. Lincoln, in Cyclic GMP: Biochemistry, Physiology and Pathophysiology (R. G. Landes Company, Austin, TX, 1994), pp. 97-115; S. M Lohmann, A. B. Vaandrager, A. Smolenski, U Walter, H. R. DeJonge, Trends Biochem. Sci. 22, 307 (1997).
18. J. P. Morgan and K. G. Morgan, J. Physiol. (London) 357, 539 (1984); T. M. Lincoln and T. L. Cornwell, FASEB J. 7, 328 (1993); T. L. Cornwell and T. M. Lincoln, J. Biol. Chem. 264, 1146 (1989); X. Wu, A. V. Somlyo, A. P. Somlyo, Biochem. Biophys. Res Commun. 220, 658 (1996); M. R. Lee, L. Li, T. Kitazawa, J. Biol. Chem. 272, 5063 (1997).
19. J. P. Morgan and K. G. Morgan, J. Physiol. (London) 357, 539 (1984); T. M. Lincoln and T. L. Cornwell, FASEB J. 7, 328 (1993); T. L. Cornwell and T. M. Lincoln, J. Biol. Chem. 264, 1146 (1989); X. Wu, A. V. Somlyo, A. P. Somlyo, Biochem. Biophys. Res Commun. 220, 658 (1996); M. R. Lee, L. Li, T. Kitazawa, J. Biol. Chem. 272, 5063 (1997).
20. J. P. Morgan and K. G. Morgan, J. Physiol. (London) 357, 539 (1984); T. M. Lincoln and T. L. Cornwell, FASEB J. 7, 328 (1993); T. L. Cornwell and T. M. Lincoln, J. Biol. Chem. 264, 1146 (1989); X. Wu, A. V. Somlyo, A. P. Somlyo, Biochem. Biophys. Res Commun. 220, 658 (1996); M. R. Lee, L. Li, T. Kitazawa, J. Biol. Chem. 272, 5063 (1997).
21. J. P. Morgan and K. G. Morgan, J. Physiol. (London) 357, 539 (1984); T. M. Lincoln and T. L. Cornwell, FASEB J. 7, 328 (1993); T. L. Cornwell and T. M. Lincoln, J. Biol. Chem. 264, 1146 (1989); X. Wu, A. V. Somlyo, A. P. Somlyo, Biochem. Biophys. Res Commun. 220, 658 (1996); M. R. Lee, L. Li, T. Kitazawa, J. Biol. Chem. 272, 5063 (1997).
22. J. P. Morgan and K. G. Morgan, J. Physiol. (London) 357, 539 (1984); T. M. Lincoln and T. L. Cornwell, FASEB J. 7, 328 (1993); T. L. Cornwell and T. M. Lincoln, J. Biol. Chem. 264, 1146 (1989); X. Wu, A. V. Somlyo, A. P. Somlyo, Biochem. Biophys. Res Commun. 220, 658 (1996); M. R. Lee, L. Li, T. Kitazawa, J. Biol. Chem. 272, 5063 (1997).
23. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
24. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
25. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
26. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
27. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
28. T. Pawson and J. D. Scott, Science 278, 2075 (1997); J. D. Scott and M L. DellAcqua, J. Biol Chem 272, 12881 (1997); J. D. Scott and M. C. Faux, Trends Biochem. Sci 21, 312 (1996); D. Mochly-Rosen, Science 268, 247 (1995); C. S. Rubin, Biochim. Biophys Acta 1224, 467 (1994); P. Cohen and M J. Hubbard, Trends Biochem. Sci. 18, 172 (1993).
29. T. M. Klauck et al., Science 271, 1589 (1996); K. Choi, B. Satterberg, D. M Lyons, E. A. Elion, Cell 78, 499 (1994).
30. T. M. Klauck et al., Science 271, 1589 (1996); K. Choi, B. Satterberg, D. M Lyons, E. A. Elion, Cell 78, 499 (1994).
31. The full-length coding region of bovine cGKIα (10) was cloned into the Gal4 DNA binding domain vector PC97 (11). cGKPC97 and a human activated T cell library (cloned into the Gal4 DNA activating domain vector PC86, gift of M. Vidal) were transformed into S. cerevisiae strain MaV103 (MATa, leu2-3, 112 trp1-901 his3△200 ade2-101 gal4△ gal80△ SPAL10-:URA3 GAL1::LacZ GAL1::HIS3@Lys2 Can1R cyh2R) using the lithium acetate method (12). Polypeptides interacting with CGKPC97 were detected by their ability to activate transcription of HIS3 and LacZ reporter genes PC86 plasmids from HIS+, LacZ+ colonies were isolated, and the library cDNA insert was sequenced. To confirm the interaction of AL9 with cGKIα, individual plasmids were reintroduced into 5. cerevisiae strain Y190 (MAT a, ura3-52, his3-200, Lys2-801, ade2-101, trp1-901, leu2-3, 112, gal4△, gal80△, cyhr2, LYS2::GAl.1UAS-HIS3TATA-HIS3, URA3::GAL1UAS-GAL1TATA-lacZ) (Clontech) by the lithium acetate method, and reporter activation was assayed as above.
32. N Tamura et al., Hypertension 27, 552 (1996)
33. P Chevray and D Nathans, Proc. Natl. Acad. Sci. U.S.A. 89, 5789 (1992); M. Vidal, R. K Brachmann, A. Fattaey, E. Harlow, J. D. Boeke, Proc. Natl. Acad. Sci U.S.A. 93, 10315 (1996).
34. P Chevray and D Nathans, Proc. Natl. Acad. Sci. U.S.A. 89, 5789 (1992); M. Vidal, R. K Brachmann, A. Fattaey, E. Harlow, J. D. Boeke, Proc. Natl. Acad. Sci U.S.A. 93, 10315 (1996).
35. R. H. D. Glatz, A. St. Jean, R. A. Woods, R. H. Schiaatll, Nucleic Acids Res. 20, 1425 (1992).
36. N. Takahashi et al., Genomics 44, 150 (1997)
37. 68-667 mutants. Pst I sites were engineered at amino acids 4 and 68 with degenerate polymerase chain reaction primers. The Pst I fragment was excised, and the COOH-terminal cGKIa was religated and transformed into yeast strain Y190. The proper reading frame was verified by DNA sequencing. Expression of the COOH-terminal construct in PC97 was confirmed by a protein immunoblot of the Y190 lysate, using the rabbit polyclonal Gal4 DNA-binding domain antibody (Upstate Biotechnology, Lake Placid, NY).
38. R. A. Atkinson, V. Saudek, J. P. Huggins, J. T. Pelton, Biochemistry 30, 9387 (1991); W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988), W M Landschulz, P. F. Johnson, S. L. McKnight, Science 243, 1681 (1989); R Turner and R. Tjian, Science 243, 1689 (1989); P. B. Harbury, T. Zhang, P. S. Kim, T. Alber, Science 262, 1401 (1993)
39. R. A. Atkinson, V. Saudek, J. P. Huggins, J. T. Pelton, Biochemistry 30, 9387 (1991); W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988), W M Landschulz, P. F. Johnson, S. L. McKnight, Science 243, 1681 (1989); R Turner and R. Tjian, Science 243, 1689 (1989); P. B. Harbury, T. Zhang, P. S. Kim, T. Alber, Science 262, 1401 (1993)
40. R. A. Atkinson, V. Saudek, J. P. Huggins, J. T. Pelton, Biochemistry 30, 9387 (1991); W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988), W M Landschulz, P. F. Johnson, S. L. McKnight, Science 243, 1681 (1989); R Turner and R. Tjian, Science 243, 1689 (1989); P. B. Harbury, T. Zhang, P. S. Kim, T. Alber, Science 262, 1401 (1993)
41. R. A. Atkinson, V. Saudek, J. P. Huggins, J. T. Pelton, Biochemistry 30, 9387 (1991); W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988), W M Landschulz, P. F. Johnson, S. L. McKnight, Science 243, 1681 (1989); R Turner and R. Tjian, Science 243, 1689 (1989); P. B. Harbury, T. Zhang, P. S. Kim, T. Alber, Science 262, 1401 (1993)
42. R. A. Atkinson, V. Saudek, J. P. Huggins, J. T. Pelton, Biochemistry 30, 9387 (1991); W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988), W M Landschulz, P. F. Johnson, S. L. McKnight, Science 243, 1681 (1989); R Turner and R. Tjian, Science 243, 1689 (1989); P. B. Harbury, T. Zhang, P. S. Kim, T. Alber, Science 262, 1401 (1993)
43. 2, 2 mM EDTA, 2 mg/ml N-dodecyl-B-maltoside, 0.4 mg/ml cholesteryl hemisuccinate, 0.6 M NaCl, 10 mM Na Molybdate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml chymostatin, 200 μg/ml aprotinin, 50 μg/ml leupeptin] and incubated for 1 hour at room temperature. Lysates were microfuged for 15 mm at 4°C, and the supernatant was incubated with 100 μI of GST-fusion protein beads overnight, followed by washing in RIPA buffer containing 1% NP40, and boiling for 5 min in SDS sample buffer. Associated proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with either rabbit anti-human cGPK-CT (Upstate Biotechnology, Lake Placid, NY) or rabbit anti-MBS antibody (Berkelely Antibody Company). The membranes were developed with ECL (Amersham Life Science).
44. H K Surks and M. E. Mendelsohn, unpublished observations.
45. Fluorescence spectroscopy was performed as previously described for the binding of cGK and vimentin (L. A. MacMillan-Crow and T. M. Lincoln, Biochemistry 33, 8035 (1994)].
46. H. Gulfreund, in Enzymes: Physical Principles (Wiley, London, 1971), pp. 67-94
47. 4,5A were each cotransformed with AL9 in yeast strain Y190, and reporter gene activation assayed as in (9).
48. 2. 2.5 mM EDTA, 1% Triton X and protease inhibitors as in buffer A). The lysate was incubated for 1 hour at room temperature, microcentrifuged 5 s, and the supernatant precleared with 12-5 μg rabbit IgG followed by protein A beads The precleared supernatant was incubated with either rabbit nonimmune IgG, or rabbit polyclonal anti-MBS (Berkeley Antibody Company) overnight, followed by harvest with protein A beads. Equal amounts of rabbit nonimmune and anti-MBS antibodies were added, and verified by Ponceau staining. SDS-PAGE and cGK immunoblots were performed as above.
49. 32P-myosin light chains were used as substrate in place of phosphorylase a, as previously described (4), and similar results were obtained Data are presented as mean ± standard error.
50. H. Ishihara et al , Biochem. Biophys. Res. Commun. 159, 871 (1989); D. L Brautigan and C. L Shriner, Methods Enzymol. 159, 339 (1988); P. Cohen, Methods Enzymol 201, 389 (1991).
51. H. Ishihara et al , Biochem. Biophys. Res. Commun. 159, 871 (1989); D. L Brautigan and C. L Shriner, Methods Enzymol. 159, 339 (1988); P. Cohen, Methods Enzymol 201, 389 (1991).
52. H. Ishihara et al , Biochem. Biophys. Res. Commun. 159, 871 (1989); D. L Brautigan and C. L Shriner, Methods Enzymol. 159, 339 (1988); P. Cohen, Methods Enzymol 201, 389 (1991).
53. 32P]ATP, for 15 min at 30°C SDS-PAGE was performed as above cGK-CA was prepared by incubating 50 μg of bovine cGKIα [purified as in T. M. Lincoln, W. L Dills, J. D. Corbin, J. Biol. Chem. 252, 4269 (1977)] with 1 μg of trypsin for 3 min at 30°C The reaction was terminated by the addition of 5 μg of soybean trypsin inhibitor. Image analysis of gel bands was performed using Scion Image software, and data are presented as mean ± SE
54. M. Nakamura et al., Cell. Signalling 9, 671 (1999).
55. C. E. Monken and G. N.Gill, J. Biol. Chem. 255, 7067 (1980); W. G. Heil, W Landgraf, F. Hofmann, Eur. J Biochem 168, 117 (1987).
56. C. E. Monken and G. N.Gill, J. Biol. Chem. 255, 7067 (1980); W. G. Heil, W Landgraf, F. Hofmann, Eur. J Biochem 168, 117 (1987).
57. Human saphenous vein smooth muscle cells of passage 2-4 were grown on coverslips, fixed with 3% paraformaldehyde then permeabilized with 0.3% Triton X 100. For preservation of stress fiber architecture prior to fixation, cells were washed on ice with PBS for 1 min and permeabilized with 0.3% Triton X in 50 mM tris (pH 7.4) with 0.5 mM PMSF, 1 μg/ml leupeptin, 1 μg/ml aprotinin, and 1 μg/ml pepstatin on ice for 1 min The cells were then washed with PBS and fixed as above. For both protocols, cells were blocked with 10% donkey serum in PBS for 1 hour at 37°C, and washed with PBS. Primary antibody mixtures were rabbit polyclonal anti-MBS (1/125), or goat polyclonal anti-cGK (1/250). Secondary antibodies were donkey anti-rabbit IgG-conjugated Cy3 (Amersham Life Science) (1/800) and donkey anti-goat IgG-conjugated fluorescein isothiocyanate (Chemicon International Inc) (1/100). Following incubation with secondary antibody, the coverslips were washed with PBS and mounted in Slow Fade (Molecular Probes).
58. G.-R. Wang, Y. Zhu, P V. Halushka, T M. Lincoln, M. E Mendelsohn, Proc. Natl. Acad. Sci. U.S.A. 95, 4888 (1998).
59. 1-59PCI by electroporation. Cells were arrested in DMEM supplemented with insulin, ascorbic acid and transferrin, then stimulated with 2 μM U46619 for 1 minute with or without 20-min pretreatment with 1 mM 8-Br-cGMP Following treatment, cells were precipitated with TCA, washed with acetone, and protein was subjected to glycerolurea electrophoresis [D. A. Taylor and J. T. Stull. J. Biol. Chem. 263, 14456 (1988)]. The nonphosphorylated and phosphorylated forms of myosin light chain were detected by immunoblotting with monoclonal anti-myosin light chain antibody (Sigma, clone MY-21). Protein bands were analyzed by densitometry Statistical analysis was performed using Student-Newman-Keuls method.
60. T. A. Kunkel, J D. Roberts, R. A. Zakour, Methods Enzymol. 154, 367 (1987)
61. We thank D. L. Brautigan for generosity with reagents and for several helpful discussions, M. Vidal for reagents and advice regarding the two hybrid screens, L. J Moss for help with confocal microscopy, and L. A. MacMillan-Crow for assistance in performing the fluorescence spectroscopy. Supported in part by NIH grants HL09330 (H.K.S.) and HL5S309 (M.E.M.). M.E.M is an Established Investigator of the American Heart Association.